Health Catalyst, Inc. (NASDAQ:HCAT) Stock Has Average Target Price of $2.45

Health Catalyst, Inc. (NASDAQ:HCAT) has been given an average recommendation of “Hold” by the eleven ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $2.45.

A number of equities research analysts recently weighed in on the stock. Citigroup lowered their price target on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating for the company in a report on Tuesday, August 11th. Weiss Ratings upgraded shares of Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 28th. Canaccord Genuity Group reissued a “hold” rating and issued a $1.80 price objective (down from $3.00) on shares of Health Catalyst in a research report on Thursday, August 20th. Finally, Wells Fargo & Company dropped their target price on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a research report on Thursday, August 13th.

Insiders Place Their Bets

In other Health Catalyst news, CEO Simeon Kohl acquired 59,000 shares of the company’s stock in a transaction on Monday, September 14th. The shares were bought at an average cost of $1.79 per share, for a total transaction of $105,610.00. Following the acquisition, the chief executive officer directly owned 2,856,385 shares of the company’s stock, valued at $5,112,929.15. This trade represents a 2.11% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 19.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Health Catalyst

Several institutional investors and hedge funds have recently made changes to their positions in HCAT. Palogic Value Management L.P. bought a new stake in shares of Health Catalyst in the second quarter worth $9,796,000. Whetstone Capital Advisors LLC boosted its stake in Health Catalyst by 0.5% during the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after acquiring an additional 19,027 shares during the last quarter. BlackRock Inc. acquired a new position in Health Catalyst during the 2nd quarter worth $3,654,000. Hsbc Holdings PLC acquired a new position in Health Catalyst during the 2nd quarter worth $809,000. Finally, Squarepoint Ops LLC increased its position in shares of Health Catalyst by 1,214.8% in the 2nd quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock worth $796,000 after purchasing an additional 369,772 shares during the last quarter. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Stock Performance

Health Catalyst stock opened at $1.76 on Thursday. The firm has a market capitalization of $132.45 million, a PE ratio of -0.48 and a beta of 1.54. Health Catalyst has a one year low of $0.96 and a one year high of $3.62. The stock’s 50 day moving average price is $1.79 and its 200 day moving average price is $1.64. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.70 and a current ratio of 2.70.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The company had revenue of $70.49 million during the quarter, compared to the consensus estimate of $69.09 million. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. As a group, sell-side analysts expect that Health Catalyst will post -0.18 EPS for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services for healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers organize clinical, operational and financial data, identify opportunities for improvement, and support more informed decisions.

The company’s offerings include its Health Catalyst Data Operating System, which integrates and manages healthcare data from multiple sources, along with analytics applications, artificial intelligence and machine-learning capabilities, and tools for population health, quality improvement, cost management and operational performance.